S

St. Francis Cancer Center | Greenville, SC

Research site

(Unclaimed)

Location

104 Innovation Drive, Greenville, South Carolina, United States of America

Site insights

Top conditions

Top treatments

AB122

GC4419

Azacitidine

MGCD516

Lintuzumab

APL-101

Venetoclax

Magrolimab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 7 total trials

Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer

The optimal treatment for Stage I or Stage IIA non-small cell lung cancer (NSCLC) remains controversial. Radiographic surveillance alone has been rec...

Enrolling

Non-Small Cell Lung Cancer

Other: 14-Gene Prognostic Assay

Drug: Adjuvant Chemotherapy

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA)

To assess:* efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification...

Enrolling

Glioblastoma Multiforme

Brain Tumor

Drug: APL-101 Oral Capsules

Study to Evaluate Safety and Clinical Activity of AB122 in Biomarker Selected Participants With Advanced Solid Tumors

This is a Phase 1b open-label study to evaluate the safety and clinical activity of zimberelimab (AB122) in biomarker-selected participants with adva...

Active, not recruiting

Advanced Solid Tumors

Drug: zimberelimab